Navigation Links
Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada
Date:8/26/2014

MONTREAL, Aug. 26, 2014  When it comes to diabetes supplies, innovations are often accused of having very little clinical relevance. But Timesulin happens to answer a real medical need.

Fitting most of insulin disposable pen on the market, Timesulin shows how long it's been since your last injection. One advantage being, indeed, preventing from missed or double insulin doses. Very easy to use, Timesulin starts automatically once it is put back on the insulin pen after an injection. There is no settings or complicated handling needed. Therefore, it enhances safety and eases daily worries for diabetic patients.

According the 2010 Novo Nordisk Gapp study (conducted among almost 3,000 physicians and patients in 8 countries), more than four in 10 people with diabetes say they struggle to effectively control their blood sugar either it is because they forget a dose, fail to take their insulin treatment properly or double their dose.  Also, 67% of patients taking insulin are concerned about experiencing a hypoglycemic event in the future.

From a public health perspective, the disease and its treatments can lead to a variety of short-term and long-term complications such as infections, slow wound healing, cardiovascular disease, vision loss, kidney failure, nerve damage, problems with pregnancy, oral disease and so on. Those health issues, as well as diabetes management itself, result in reduced quality of life, work limitations and higher risk of early death. They also greatly increase the need for health care resources and the economic burden of diabetes for society.

Widely used, Timesulin cap could help avoid hypo or hyperglycemic episodes and related complications and reduce future diabetes-related expenditures.

By securing reimbursement for Timesulin, Montméd and insurance companies have shown their understanding of the complexity of care in diabetes and their commitment to diversify the ways to make diabetes management simplermake diabetes management simplermake diabetes management simpler.

"For Montméd, having Timesulin reimbursed by benefit plans was a matter of equality. Since public healthcare coverage in Canada is rather uneven across the country because it is within competences of provinces and territories, we wanted to ensure accessibility to Timesulin for as many diabetics as possible because it can really make a difference in their lives." Gino Henry, General Manager of Montméd for Canada.

Timesulin's reimbursement has been approved by:

Great West Life

Manulife Financiel

Sun Life Financial

Industrial Alliances

Medavie Blue Cross

Empire Life

Standard Life

Equitable Life

Desjardins

About montméd :

Montméd is a Canadian manufacturer and distributor of medical devices within the area of diabetes and self-care. Its range of products includes insulin syringes, pen needles, thermometers, blood pressure monitors, skin care, insulin cooling wallet and so on. Montméd focuses on bringing a unique touch to each of its product, aligned with users' needs. It offers advices, news and educational tools to both patients and health-care professionals through its Health Street program. 
The company also provides global distribution and marketing services for other medical equipment firms.

"Simple and unique innovations that make a difference"

Version française disponible sur demande.


'/>"/>
SOURCE Montméd
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. montméd, Inc. to Market FRiO Insulin Wallets in 20 countries of Middle East and North Africa
2. Montmed to Participate in 2013 Advanced Technologies and Treatments for Diabetes Conference
3. montmed to participate in Vascular 2013
4. Montmed to Launch DiaClin General & Diabetic Skin Care Product Line for Canadian Marketplace
5. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
6. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
7. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
8. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
9. Andrew Technologies Obtains Patent for Visceral Lipectomy Application from USPTO
10. BioElectronics Obtains Additional US Patent For Its Unique Pain Devices
11. Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Intalere, the healthcare industry leader ... “Make Plans for MACRA,” highlighting the impact of the Medicare Access and ... physicians and other clinicians are reimbursed for the care they deliver in Medicare. ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... thrilled to announce the ATA 2017 President’s Awards recipients, comprised of organizations ... superior healthcare delivery. , The ATA 2017 President’s Awards recognize individuals ...
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of a pioneering ... , the largest Electronic Medical Records (EMR) provider in South Africa. By using ... a patient’s remote health progress, empowering the patient to take direct responsibility for their ...
(Date:4/26/2017)... ... April 26, 2017 , ... The National Business ... National Registry of Emergency Medical Technicians and welcomes this organization to ... Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... Miami native ... as a dentist. , “I could have never imagined back in 1991 that this ... said Dr. Gallardo. , Over the last 25 years, Dr. Gallardo has pioneered implant ...
Breaking Medicine News(10 mins):